Abstract
Ever since the discovery of the transforming retroviral v-sis oncogene, which encodes PDGF-B, PDGF signaling has been an interesting target for cancer treatment. In the last few years, compelling evidence supports the essential role of PDGF signaling for cancer cell proliferation and tumor angiogenesis in several types of human cancers, including nonmelanoma skin cancers. BCCs, the commonest human cancer, contain activation of the hedgehog pathway, frequently through inactivated mutations of tumor suppressor gene PTCH1. How does activation of the hedgehog pathway promote cell proliferation in the tumor? Our data indicate that PDGFRα activation is important for hedgehog signaling-mediated cell proliferation in BCCs. These findings not only detail the molecular basis of hedgehog-mediated tumorigenesis but also provide new designs for skin cancer therapeutics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Heldin CH, Ostman A, Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1998; 1378(1):F79–113.
Ostman A, Heldin CH. Involvement of platelet-derived growth factor in disease: Development of specific antagonists. Adv Cancer Res 2001; 80:1–38.
Yu J, Ustach C, Kim HR. Platelet-derived growth factor signaling and human cancer. J Biochem Mol Biol 2003; 36(1):49–59.
Hoch RV, Soriano P. Roles of PDGF in animal development. Development 2003; 130:4769–4784.
Betsholtz C. Biology of platelet-derived growth factors in development. Birth Defects Res Part C Embryo Today 2003; 69(4):272–285.
Li X, Ponten A, Aase K et al. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2000; 2(5):302–309.
LaRochelle WJ, Jeffers M, McDonald WF et al. PDGF-D, a new protease-activated growth factor. Nat Cell Biol 2001; 3(5):517–521.
Bergsten E, Uutela M, Li X et al. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol 2001; 3(5):512–516.
Soriano P. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development 1997; 124(14):2691–2700.
Bostrom H, Willetts K, Pekny M et al. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 1996; 85(6):863–873.
Clarke ID, Dirks PB. A human brain tumor-derived PDGFR-alpha deletion mutant is transforming. Oncogene 2003; 22(5):722–733.
Uhrbom L, Hesselager G, Nister M et al. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res 1998; 58(23):5275–5279.
Dai C, Celestino JC, Okada Y et al. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 2001; 15(15):1913–1925.
Kilic T, Alberta JA, Zdunek PR et al. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res 2000; 60(18):5143–5150.
Lokker NA, Sullivan CM, Hollenbach SJ et al. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: Evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 2002; 62(13):3729–3735.
Heinrich MC, Corless CL, Duensing A et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003; 299(5607):708–710.
Sommer G, Agosti V, Ehlers I et al. Gastrointestinal stromal tumors in a mouse model by targeted mutation of the kit receptor tyrosine kinase. Proc Nad Acad Sci USA 2003; 100(11):6706–6711.
Heinrich MC, Corless CL, Demetri GD et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003; 21(23):4342–4349.
Golub TR, Barker GF, Lovett M et al. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994; 77(2):307–316.
Carroll M, Tomasson MH, Barker GF et al. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways. Proc Natl Acad Sci USA 1996; 93(25):14845–14850.
Baxter EJ, Hochhaus A, Bolufer P et al. The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA. Hum Mol Genet 2002; 11(12):1391–1397.
Andrae J, Molander C, Smits A et al. Platelet-derived growth factor-B and-C and active alpha-receptors in medulloblastoma cells. Biochem Biophys Res Commun 2002; 296(3):604–611.
Gilbertson RJ, Clifford SC. PDGFRB is overexpressed in metastatic medulloblastoma. Nat Genet 2003; 35(3):197–198.
Johnson RL, Rothman AL, Xie J et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996; 272(5268):1668–1671.
Hahn H, Wicking C, Zaphiropoulous PG et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996; 85(6):841–851.
Xie J, Quinn A, Zhang X et al. Physical mapping of the 5 Mb D9S196-D9S180 interval harboring the basal cell nevus syndrome gene and localization of six genes in this region. Genes Chromosomes Cancer 1997; 18(4):305–309.
Quinn AG, Epstein Jr E. Patched, hedgehog, and skin cancer. Methods Mol Biol 2003; 222:85–95.
Bale AE, Yu KP. The hedgehog pathway and basal cell carcinomas. Hum Mol Genet 2001; 10(7):757–762.
Toftgard R. Hedgehog signaling in cancer. Cell Mol Life Sci 2000; 57(12):1720–1731.
Wicking C, Bale AE. Molecular basis of the nevoid basal cell carcinoma syndrome. Curr Opin Pediatr 1997; 9(6):630–635.
Goodrich LV, Milenkovic L, Higgins KM et al. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997; 277(5329):1109–1113.
Hahn H, Wojnowski L, Zimmer AM et al. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat Med 1998; 4(5):619–622.
Aszterbaum M, Epstein J, Oro A et al. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 1999; 5(11):1285–1291.
Xie J, Murone M, Luoh SM et al. Activating smoothened mutations in sporadic basal-cell carcinoma. Nature 1998; 391(6662):90–92.
Lam CW, Xie J, To KF et al. A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 1999; 18(3):833–836.
Reifenberger J, Wolter M, Weber RG et al. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1998; 58(9):1798–1803.
Xie J, Johnson RL, Zhang X et al. Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer Res 1997; 57(12):2369–2372.
Berman DM, Karhadkar SS, Maitra A et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumors. Nature 2003; 425:846–51.
Thayer S et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003; 425:851–6.
Watkins DN, Berman DM, Burkholder SG et al. Hedgehog signaling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003; 422(6929):313–317.
Wechsler-Reya RJ, Scott MP. Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 1999; 22(1):103–114.
Wallace VA. Purkinje-cell-derived Sonic hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum. Curr Biol 1999; 9(8):445–448.
Oliver TG, Grasfeder LL, Carroll AL et al. Transcriptional profiling of the Sonic hedgehog response: A critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci USA 2003; 100(12):7331–7336.
Allen M, Grachtchouk M, Sheng H et al. Hedgehog signaling regulates sebaceous gland development. Am J Pathol 2003; 163(6):2173–2178.
Niemann C, Unden AB, Lyle S et al. Indian hedgehog and beta-catenin signaling: Role in the sebaceous lineage of normal and neoplastic mammalian epidermis. Proc Natl Acad Sci USA 2003; 100(Suppl 1):11873–11880.
Mill P, Mo R, Fu H et al. Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development. Genes Dev 2003; 17(2):282–294.
Milenkovic L, Goodrich LV, Higgins KM et al. Mouse patched1 controls body size determination and limb patterning. Development 1999; 126(20):4431–4440.
Xie J, Aszterbaum M, Zhang X et al. A role of PDGFRalpha in basal cell carcinoma proliferation. Proc Natl Acad Sci USA 2001; 98(16):9255–9259.
Ninck S, Reisser C, Dyckhoff G et al. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck. Int J Cancer 2003; 106(1):34–44.
Gleich LL, Srivastava L, Gluckman JL. Plasma platelet-derived growth factor: Preliminary study of a potential marker in head and neck cancer. Ann Otol Rhinol Laryngol 1996; 105(9):710–712.
Zhang JZ, Maruyama K, Ono I et al. Production and secretion of platelet-derived growth factor AB by cultured human keratinocytes: Regulatory effects of phorbol 12-myristate 13-acetate, etretinate, 1,25-dihydroxyvitamin D3, and several cytokines. J Dermatol 1995; 22(5):305–309.
Mueller MM, Fusenig NE. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation 2002; 70(9–10):486–497.
Simon MP, Pedeutour F, Sirvent N et al. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet 1997; 15(1):95–98.
Greco A, Fusetti L, Villa R et al. Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans. Oncogene 1998; 17(10):1313–1319.
Sjoblom T, Shimizu A, O’Brien KP et al. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Cancer Res 2001; 61(15):5778–5783.
Rubin BP, Schuetze SM, Eary JF et al. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J Clin Oncol 2002; 20(17):3586–3591.
Li CX, Chi S, He N et al. INF alpha induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling. Oncogene 2004; 23(8):1608–17.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Xie, J. (2006). PDGF Pathways and Growth of Basal Cell and Squamous Cell Carcinomas. In: Molecular Mechanisms of Basal Cell and Squamous Cell Carcinomas. Medical Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/0-387-35098-5_10
Download citation
DOI: https://doi.org/10.1007/0-387-35098-5_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-26046-4
Online ISBN: 978-0-387-35098-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)